Related Experiment Videos
Melanocyte stimulating hormone (MSH) in the restless-legs syndrome
1Department of Neurology, University of Arizona, Tucson 85724.
The International Journal of Neuroscience
|June 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Resolution of partial cataplexy in multiple sclerosis by treatment with weak electromagnetic fields.
The International journal of neuroscience·1996
Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields.
The International journal of neuroscience·1995
Weak electromagnetic fields improve body image perception in patients with multiple sclerosis.
The International journal of neuroscience·1995
Reversal of visuospatial deficit on the Clock Drawing Test in Parkinson's disease by treatment with weak electromagnetic fields.
The International journal of neuroscience·1995
Improvement of body image perception in Parkinson's disease by treatment with weak electromagnetic fields.
The International journal of neuroscience·1995
Weak electromagnetic fields restore dream recall in patients with multiple sclerosis.
The International journal of neuroscience·1995
Aquaporin-4 mediated glymphatic dysfunction and neuroinflammatory signaling in neurodegenerative disorders.
The International journal of neuroscience·2026
Combined assessment of established biomarkers: monocyte-to-HDL ratio and carotid IMT in association with acute ischemic stroke.
The International journal of neuroscience·2026
miR-4508 targets PLCB2 in propofol-induced neurotoxicity in sH-SY5Y cells: role and mechanism.
The International journal of neuroscience·2026
Diagnostic value of miR-34c-5p in acute cerebral infarction and its correlation with prognostic outcomes of rehabilitation.
The International journal of neuroscience·2026
Real‑world implementation of rTMS for depression: a comparative study of Sweden and Japan.
Nordic journal of psychiatry·2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
American journal of hematology·2026
Rapid versus conventional glucocorticoid tapering in pure membranous LN: a multicentre retrospective study.
Rheumatology advances in practice·2026